101 – 110 of 174
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Suppression of Map Kinases Inhibits Microglial Activation and Attenuates Neuronal Cell Death Induced by Alpha-Synuclein Protofibrils
(
- Contribution to journal › Article
-
Mark
Scientific rationale for the development of gene therapy strategies for Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Are the animal models of Parkinson's disease suitable for development of neuroprotective therapies?
2009) 4th European-Society-for-Neurochemistry Conference on Advances in Molecular Mechanisms of Neurological Disorders In Journal of Neurochemistry 110(Suppl 1). p.63-63(
- Contribution to journal › Published meeting abstract
-
Mark
Dose Optimization for Long-term rAAV-mediated RNA Interference in the Nigrostriatal Projection Neurons.
(
- Contribution to journal › Article
- 2008
-
Mark
In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway
(
- Contribution to journal › Article
-
Mark
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
In vivo gene delivery for development of mammalian models for Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Is alpha-synuclein the culprit of the Parkinsonian neurodegeneration?
(
- Contribution to journal › Letter
-
Mark
Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Applications of lentiviral vectors for biology and gene therapy of neurological disorders.
(
- Contribution to journal › Article